AstraZeneca Pharma India Files FY26 BRSR Report

AstraZeneca Pharma India Ltd has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. The report, which includes an Independent Practitioner's Limited Assurance Report from KPMG Assurance and Consulting Services LLP, details the company's commitment to responsible, resilient, and sustainable business practices. The BRSR outlines AstraZeneca's approach to making a sustainable impact through science and innovation, focusing on climate and nature, health equity, and health systems resilience. It also covers how the company conducts its business ethically and with robust governance. The report provides corporate details, including CIN, registered office, financial year, paid-up capital, and contact information for queries. It also details business activities, primarily marketing and trading of pharmaceuticals contributing 90% of turnover, and lists 'Drugs and Pharmaceutical products' as its main product category.